Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial

Objectives The absolute annual risk of patients with Barrett's oesophagus (BO) developing oesophageal adenocarcinoma (OAC) is ≤0.5%. Screening BO patients for malignant progression using endoscopic surveillance is widely practised. To assess the efficacy and cost-effectiveness of this, we devel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medical screening 2015-09, Vol.22 (3), p.158-164
Hauptverfasser: Old, Oliver, Moayyedi, Paul, Love, Sharon, Roberts, Corran, Hapeshi, Julie, Foy, Chris, Stokes, Clive, Briggs, Andrew, Jankowski, Janusz, Barr, Hugh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!